+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pyrogen Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 444 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5934302
The global pyrogen testing market attained a substantial valuation in 2024, with a projected significant growth over the next decade. This indicates a highly positive trend for market expansion. Detailed industry analysis reveals that revenue from pyrogen testing will surge to a market valuation of US$4.58 Bn by the end of 2031.

Key Drivers of Market Growth:

The proliferation of chronic illnesses worldwide has underscored the need for stringent quality testing in medical products and services. Pyrogen testing, governed by standards set by prominent organizations such as the FDA, USP, and EP, has emerged as a critical tool in ensuring the safety and efficacy of pharmaceuticals and medical devices.

Technological Advancements Reshaping the Landscape:

The introduction of innovative testing methodologies such as the Monocyte Activation Test (MAT) has revolutionized the field of pyrogen testing. Offering superior sensitivity and accuracy compared to traditional animal-based tests, MAT has garnered significant traction among healthcare product manufacturers, driving market expansion.

Regional Insights:

  • United States: With a market share of 94.2%, the U.S. remains a dominant force in the global pyrogen testing market. Frequent approvals by the FDA fuel product launches, making the country a lucrative destination for manufacturers.
  • Germany: Accounting for 23.1% of the European market, Germany boasts a robust presence of major industry players, fostering product availability and market growth.
  • China: High levels of research activities and strategic collaborations are propelling China to the forefront of the global pyrogen testing market, offering abundant opportunities for local manufacturers.
  • India: With a market share of 48.3% in South Asia, India's pyrogen testing market is buoyed by a pool of skilled labor and favorable manpower costs, driving demand for testing services.

Category-wise Insights:

  • Pyrogen Test Kits & Reagents: This segment, accounting for 43.2% of market revenue in 2023, is witnessing heightened demand driven by the emergence of COVID-19 and increased diagnostic activities.
  • Animal-based Tests: Despite advancements in alternative methodologies, animal-based tests remain predominant, comprising over 86.5% of the market share in 2023.

End User Dynamics:

Pharmaceutical companies, comprising 44.7% of the market share, are at the forefront of adopting advanced pyrogen testing methods. The transition away from traditional rabbit pyrogen tests towards more sensitive and human-specific alternatives is poised to drive market growth further.

Competitive Analysis:

Key players in the pyrogen testing market are focusing on gaining regulatory approvals, launching innovative products, and strategic acquisitions to enhance their market presence. Recent developments include Eurofins' PFAS Exposure™ test, ACC's PyroSmart NextGen™, and Lonza's Pyro Cell Monocyte Activation Test System.

As the global healthcare landscape continues to evolve, the pyrogen testing market stands poised for exponential growth, propelled by technological innovations, regulatory reforms, and increasing demand for safe and effective medical products.

Key companies functioning in the global pyrogen testing market including:

  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza
  • MAT-BioTech
  • Promega Corporation
  • GenScript
  • Associates of Cape Cod, Inc.
  • BIOMERIEUX SA
  • Ella A/S
  • Hycult Biotech Inc.
  • Eurofins Biolab Srl
  • Solvias AG
  • Wickham Laboratories Ltd.
  • Sotera Health (Nelson Laboratories, LLC)
  • Charles River Laboratories
  • Creative Biolabs
  • Sanquin Reagents B.V.
  • Fujifilm Wako Pure Chemical Corporation
  • MAT Research
  • Xiamen Bioendo Technology Co. Ltd.
  • Microcoat Biotechnologie GmbH
  • PerkinElmer Inc.
  • Orchid Scientific & Innovative Pvt Ltd.

Key Segments Covered in Pyrogen Testing Industry Survey

Pyrogen Testing Market by Product & Service:

  • Instruments
  • Digital Tele Thermometers Equipment
  • Automated Endotoxin Testing Equipment
  • Portable Endotoxin Testing Equipment
  • Microplate Readers
  • Test Kits & Reagents
  • Recombinant Factor C Assays
  • Limulus Amebocyte Lysate (LAL) Tests
  • Chromogenic Tests
  • Turbid metric Tests
  • Gel-Clot Tests
  • Rabbit Pyrogen Tests
  • Monocyte Activity Assays
  • Consumables
  • Services
  • Endotoxin Testing Services
  • Monocyte Activation Testing Services

Pyrogen Testing Market by Source:

  • In-vitro-based Pyrogen Testing
  • Whole Blood-based Monocytes
  • Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
  • Cell Line-based Monocytes
  • Animal-based Pyrogen Testing
  • Recombinant Factor (rFC )
  • Bacterial Endotoxins (BET)
  • Rabbit Pyrogen Tests

Pyrogen Testing Market by Application:

  • Injectable Therapeutics
  • Vaccines
  • Orally-dosed Pharmaceuticals
  • Biologics
  • Implantable Medical Devices
  • Dialysis Liquids
  • Toxic/immune-modulatory Drugs
  • Blood-based Products

Pyrogen Testing Market by End User:

  • Pharmaceuticals Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Diagnostic Laboratories
  • Clinical Research Organizations (CROs)
  • Clinical Manufacturing Organizations (CMOs)

Pyrogen Testing Market by Region:

  • North America Pyrogen Testing Market
  • Latin America Pyrogen Testing Market
  • Europe Pyrogen Testing Market
  • South Asia Pyrogen Testing Market
  • East Asia Pyrogen Testing Market
  • Oceania Pyrogen Testing Market
  • Middle East & Africa Pyrogen Testing Market


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Pyrogen Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2018 - 2023
3.1. Global Pyrogen Testing Market Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2018 - 2023
4.1. Global Average Price Analysis, by Product and Services/ Material, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Pyrogen Testing Market Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Pyrogen Testing Market Outlook, 2018 - 2031
5.1. Global Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Instruments
5.1.1.1.1. Digital Tele Thermometers Equipment
5.1.1.1.2. Automated Endotoxin Testing Equipment
5.1.1.1.3. Portable Endotoxin Testing Equipment
5.1.1.1.4. Microplate Readers
5.1.1.2. Test Kits & Reagents
5.1.1.2.1. Recombinant Factor C Assays
5.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
5.1.1.2.2.1. Chromogenic Tests
5.1.1.2.2.2. Turbid metric Tests
5.1.1.2.2.3. Gel-Clot Tests
5.1.1.2.3. Rabbit Pyrogen Tests
5.1.1.2.4. Monocyte Activity Assays
5.1.1.3. Consumables
5.1.1.4. Services
5.1.1.4.1. Endotoxin Testing Services
5.1.1.4.2. Monocyte Activation Testing Services
5.2. Global Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. In-vitro-based Pyrogen Testing
5.2.1.1.1. Whole Blood-based Monocytes
5.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
5.2.1.1.3. Cell Line-based Monocytes
5.2.1.2. Animal-based Pyrogen Testing
5.2.1.2.1. Recombinant Factor (rFC )
5.2.1.2.2. Bacterial Endotoxins (BET)
5.2.1.2.3. Rabbit Pyrogen Tests
5.3. Global Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Injectable Therapeutics
5.3.1.2. Vaccines
5.3.1.3. Orally-dosed Pharmaceuticals
5.3.1.4. Biologics
5.3.1.5. Implantable Medical Devices
5.3.1.6. Dialysis Liquids
5.3.1.7. Toxic/immune-modulatory Drugs
5.3.1.8. Blood-based Products
5.4. Global Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Pharmaceuticals Companies
5.4.1.2. Biotechnology Companies
5.4.1.3. Medical Device Companies
5.4.1.4. Diagnostic Laboratories
5.4.1.5. Clinical Research Organizations (CROs)
5.4.1.6. Clinical Manufacturing Organizations (CMOs)
5.5. Global Pyrogen Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. North America
5.5.1.2. Europe
5.5.1.3. Asia Pacific
5.5.1.4. Latin America
5.5.1.5. Middle East & Africa
6. North America Pyrogen Testing Market Outlook, 2018 - 2031
6.1. North America Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Instruments
6.1.1.1.1. Digital Tele Thermometers Equipment
6.1.1.1.2. Automated Endotoxin Testing Equipment
6.1.1.1.3. Portable Endotoxin Testing Equipment
6.1.1.1.4. Microplate Readers
6.1.1.2. Test Kits & Reagents
6.1.1.2.1. Recombinant Factor C Assays
6.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
6.1.1.2.2.1. Chromogenic Tests
6.1.1.2.2.2. Turbid metric Tests
6.1.1.2.2.3. Gel-Clot Tests
6.1.1.2.3. Rabbit Pyrogen Tests
6.1.1.2.4. Monocyte Activity Assays
6.1.1.3. Consumables
6.1.1.4. Services
6.1.1.4.1. Endotoxin Testing Services
6.1.1.4.2. Monocyte Activation Testing Services
6.2. North America Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. In-vitro-based Pyrogen Testing
6.2.1.1.1. Whole Blood-based Monocytes
6.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
6.2.1.1.3. Cell Line-based Monocytes
6.2.1.2. Animal-based Pyrogen Testing
6.2.1.2.1. Recombinant Factor (rFC )
6.2.1.2.2. Bacterial Endotoxins (BET)
6.2.1.2.3. Rabbit Pyrogen Tests
6.3. North America Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Injectable Therapeutics
6.3.1.2. Vaccines
6.3.1.3. Orally-dosed Pharmaceuticals
6.3.1.4. Biologics
6.3.1.5. Implantable Medical Devices
6.3.1.6. Dialysis Liquids
6.3.1.7. Toxic/immune-modulatory Drugs
6.3.1.8. Blood-based Products
6.4. North America Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Pharmaceuticals Companies
6.4.1.2. Biotechnology Companies
6.4.1.3. Medical Device Companies
6.4.1.4. Diagnostic Laboratories
6.4.1.5. Clinical Research Organizations (CROs)
6.4.1.6. Clinical Manufacturing Organizations (CMOs)
6.5. North America Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. U.S. Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.2. U.S. Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.3. U.S. Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.4. U.S. Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.5. Canada Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.6. Canada Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.7. Canada Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.8. Canada Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Pyrogen Testing Market Outlook, 2018 - 2031
7.1. Europe Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Instruments
7.1.1.1.1. Digital Tele Thermometers Equipment
7.1.1.1.2. Automated Endotoxin Testing Equipment
7.1.1.1.3. Portable Endotoxin Testing Equipment
7.1.1.1.4. Microplate Readers
7.1.1.2. Test Kits & Reagents
7.1.1.2.1. Recombinant Factor C Assays
7.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
7.1.1.2.2.1. Chromogenic Tests
7.1.1.2.2.2. Turbid metric Tests
7.1.1.2.2.3. Gel-Clot Tests
7.1.1.2.3. Rabbit Pyrogen Tests
7.1.1.2.4. Monocyte Activity Assays
7.1.1.3. Consumables
7.1.1.4. Services
7.1.1.4.1. Endotoxin Testing Services
7.1.1.4.2. Monocyte Activation Testing Services
7.2. Europe Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. In-vitro-based Pyrogen Testing
7.2.1.1.1. Whole Blood-based Monocytes
7.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
7.2.1.1.3. Cell Line-based Monocytes
7.2.1.2. Animal-based Pyrogen Testing
7.2.1.2.1. Recombinant Factor (rFC )
7.2.1.2.2. Bacterial Endotoxins (BET)
7.2.1.2.3. Rabbit Pyrogen Tests
7.3. Europe Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Injectable Therapeutics
7.3.1.2. Vaccines
7.3.1.3. Orally-dosed Pharmaceuticals
7.3.1.4. Biologics
7.3.1.5. Implantable Medical Devices
7.3.1.6. Dialysis Liquids
7.3.1.7. Toxic/immune-modulatory Drugs
7.3.1.8. Blood-based Products
7.4. Europe Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.1. Pharmaceuticals Companies
7.4.1.2. Biotechnology Companies
7.4.1.3. Medical Device Companies
7.4.1.4. Diagnostic Laboratories
7.4.1.5. Clinical Research Organizations (CROs)
7.4.1.6. Clinical Manufacturing Organizations (CMOs)
7.5. Europe Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Germany Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.2. Germany Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.3. Germany Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.4. Germany Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.5. U.K. Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.6. U.K. Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.7. U.K. Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.8. U.K. Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.9. France Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.10. France Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.11. France Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.12. France Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.13. Italy Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.14. Italy Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.15. Italy Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.16. Italy Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.17. Turkey Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.18. Turkey Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.19. Turkey Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.20. Turkey Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.21. Russia Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.22. Russia Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.23. Russia Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.24. Russia Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.25. Rest of Europe Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.26. Rest of Europe Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.27. Rest of Europe Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.28. Rest of Europe Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Pyrogen Testing Market Outlook, 2018 - 2031
8.1. Asia Pacific Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Instruments
8.1.1.1.1. Digital Tele Thermometers Equipment
8.1.1.1.2. Automated Endotoxin Testing Equipment
8.1.1.1.3. Portable Endotoxin Testing Equipment
8.1.1.1.4. Microplate Readers
8.1.1.2. Test Kits & Reagents
8.1.1.2.1. Recombinant Factor C Assays
8.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
8.1.1.2.2.1. Chromogenic Tests
8.1.1.2.2.2. Turbid metric Tests
8.1.1.2.2.3. Gel-Clot Tests
8.1.1.2.3. Rabbit Pyrogen Tests
8.1.1.2.4. Monocyte Activity Assays
8.1.1.3. Consumables
8.1.1.4. Services
8.1.1.4.1. Endotoxin Testing Services
8.1.1.4.2. Monocyte Activation Testing Services
8.2. Asia Pacific Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. In-vitro-based Pyrogen Testing
8.2.1.1.1. Whole Blood-based Monocytes
8.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
8.2.1.1.3. Cell Line-based Monocytes
8.2.1.2. Animal-based Pyrogen Testing
8.2.1.2.1. Recombinant Factor (rFC )
8.2.1.2.2. Bacterial Endotoxins (BET)
8.2.1.2.3. Rabbit Pyrogen Tests
8.3. Asia Pacific Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Injectable Therapeutics
8.3.1.2. Vaccines
8.3.1.3. Orally-dosed Pharmaceuticals
8.3.1.4. Biologics
8.3.1.5. Implantable Medical Devices
8.3.1.6. Dialysis Liquids
8.3.1.7. Toxic/immune-modulatory Drugs
8.3.1.8. Blood-based Products
8.4. Asia Pacific Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Pharmaceuticals Companies
8.4.1.2. Biotechnology Companies
8.4.1.3. Medical Device Companies
8.4.1.4. Diagnostic Laboratories
8.4.1.5. Clinical Research Organizations (CROs)
8.4.1.6. Clinical Manufacturing Organizations (CMOs)
8.5. Asia Pacific Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. China Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.2. China Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.3. China Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.4. China Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.5. Japan Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.6. Japan Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.7. Japan Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.8. Japan Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.9. South Korea Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.10. South Korea Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.11. South Korea Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.12. South Korea Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.13. India Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.14. India Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.15. India Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.16. India Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.17. Southeast Asia Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.18. Southeast Asia Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.19. Southeast Asia Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.20. Southeast Asia Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.21. Rest of Asia Pacific Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.22. Rest of Asia Pacific Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.23. Rest of Asia Pacific Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.24. Rest of Asia Pacific Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Pyrogen Testing Market Outlook, 2018 - 2031
9.1. Latin America Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.1.1. Key Highlights
9.1.1.1. Instruments
9.1.1.1.1. Digital Tele Thermometers Equipment
9.1.1.1.2. Automated Endotoxin Testing Equipment
9.1.1.1.3. Portable Endotoxin Testing Equipment
9.1.1.1.4. Microplate Readers
9.1.1.2. Test Kits & Reagents
9.1.1.2.1. Recombinant Factor C Assays
9.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
9.1.1.2.2.1. Chromogenic Tests
9.1.1.2.2.2. Turbid metric Tests
9.1.1.2.2.3. Gel-Clot Tests
9.1.1.2.3. Rabbit Pyrogen Tests
9.1.1.2.4. Monocyte Activity Assays
9.1.1.3. Consumables
9.1.1.4. Services
9.1.1.4.1. Endotoxin Testing Services
9.1.1.4.2. Monocyte Activation Testing Services
9.2. Latin America Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.2.1.1. In-vitro-based Pyrogen Testing
9.2.1.1.1. Whole Blood-based Monocytes
9.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
9.2.1.1.3. Cell Line-based Monocytes
9.2.1.2. Animal-based Pyrogen Testing
9.2.1.2.1. Recombinant Factor (rFC )
9.2.1.2.2. Bacterial Endotoxins (BET)
9.2.1.2.3. Rabbit Pyrogen Tests
9.3. Latin America Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Injectable Therapeutics
9.3.1.2. Vaccines
9.3.1.3. Orally-dosed Pharmaceuticals
9.3.1.4. Biologics
9.3.1.5. Implantable Medical Devices
9.3.1.6. Dialysis Liquids
9.3.1.7. Toxic/immune-modulatory Drugs
9.3.1.8. Blood-based Products
9.4. Latin America Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. Pharmaceuticals Companies
9.4.1.2. Biotechnology Companies
9.4.1.3. Medical Device Companies
9.4.1.4. Diagnostic Laboratories
9.4.1.5. Clinical Research Organizations (CROs)
9.4.1.6. Clinical Manufacturing Organizations (CMOs)
9.5. Latin America Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1. Key Highlights
9.5.1.1. Brazil Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.2. Brazil Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.3. Brazil Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.4. Brazil Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.5. Mexico Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.6. Mexico Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.7. Mexico Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.8. Mexico Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.9. Argentina Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.10. Argentina Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.11. Argentina Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.12. Argentina Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.13. Rest of Latin America Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.14. Rest of Latin America Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.15. Rest of Latin America Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.16. Rest of Latin America Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Pyrogen Testing Market Outlook, 2018 - 2031
10.1. Middle East & Africa Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.1.1. Key Highlights
10.1.1.1. Instruments
10.1.1.1.1. Digital Tele Thermometers Equipment
10.1.1.1.2. Automated Endotoxin Testing Equipment
10.1.1.1.3. Portable Endotoxin Testing Equipment
10.1.1.1.4. Microplate Readers
10.1.1.2. Test Kits & Reagents
10.1.1.2.1. Recombinant Factor C Assays
10.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
10.1.1.2.2.1. Chromogenic Tests
10.1.1.2.2.2. Turbid metric Tests
10.1.1.2.2.3. Gel-Clot Tests
10.1.1.2.3. Rabbit Pyrogen Tests
10.1.1.2.4. Monocyte Activity Assays
10.1.1.3. Consumables
10.1.1.4. Services
10.1.1.4.1. Endotoxin Testing Services
10.1.1.4.2. Monocyte Activation Testing Services
10.2. Middle East & Africa Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.2.1. Key Highlights
10.2.1.1. In-vitro-based Pyrogen Testing
10.2.1.1.1. Whole Blood-based Monocytes
10.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
10.2.1.1.3. Cell Line-based Monocytes
10.2.1.2. Animal-based Pyrogen Testing
10.2.1.2.1. Recombinant Factor (rFC )
10.2.1.2.2. Bacterial Endotoxins (BET)
10.2.1.2.3. Rabbit Pyrogen Tests
10.3. Middle East & Africa Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.3.1. Key Highlights
10.3.1.1. Injectable Therapeutics
10.3.1.2. Vaccines
10.3.1.3. Orally-dosed Pharmaceuticals
10.3.1.4. Biologics
10.3.1.5. Implantable Medical Devices
10.3.1.6. Dialysis Liquids
10.3.1.7. Toxic/immune-modulatory Drugs
10.3.1.8. Blood-based Products
10.4. Middle East & Africa Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.4.1. Key Highlights
10.4.1.1. Pharmaceuticals Companies
10.4.1.2. Biotechnology Companies
10.4.1.3. Medical Device Companies
10.4.1.4. Diagnostic Laboratories
10.4.1.5. Clinical Research Organizations (CROs)
10.4.1.6. Clinical Manufacturing Organizations (CMOs)
10.5. Middle East & Africa Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1. Key Highlights
10.5.1.1. GCC Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.2. GCC Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.3. GCC Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.4. GCC Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.5. South Africa Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.6. South Africa Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.7. South Africa Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.8. South Africa Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.9. Egypt Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.10. Egypt Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.11. Egypt Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.12. Egypt Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.13. Nigeria Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.14. Nigeria Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.15. Nigeria Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.16. Nigeria Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.17. Rest of Middle East & Africa Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.18. Rest of Middle East & Africa Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.19. Rest of Middle East & Africa Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.20. Rest of Middle East & Africa Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Product vs Indication Heatmap
11.2. Company Market Share Analysis, 2022
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Thermo Fisher Scientific
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Merck KgaA
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. LONZA
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. MAT- BioTech
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Promega Corporation
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. GenScript
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. ASSOCIATES OF CAPE COD, INC.,
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. BioMérieux SA
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Ellab A/S
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. Hycult Biotech
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Eurofins Biolab Srl
11.4.11.1. Company Overview
11.4.11.2. Product Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
11.4.12. SOLVIAS AG, Wickham Laboratories Ltd.
11.4.12.1. Company Overview
11.4.12.2. Product Portfolio
11.4.12.3. Financial Overview
11.4.12.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Thermo Fisher Scientific
  • Merck KgaA
  • LONZA
  • MAT- BioTech
  • Promega Corporation
  • GenScript
  • ASSOCIATES OF CAPE COD, INC.,
  • BioMérieux SA
  • Ellab A/S
  • Hycult Biotech
  • Eurofins Biolab Srl
  • SOLVIAS AG, Wickham Laboratories Ltd.

Methodology

Loading
LOADING...